key: cord-0015372-qgfra9c7 authors: Bazine, Ismahene; Bendjedid, Samira; Boukhari, Abbes title: Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety date: 2020-12-07 journal: Arch Pharm (Weinheim) DOI: 10.1002/ardp.202000291 sha: 52e3c3b52d77c6bd10790926b4ddc7ac90f2d42d doc_id: 15372 cord_uid: qgfra9c7 A series of new α‐sulfamidophosphonate/sulfonamidophosphonate (4a–n) and cyclosulfamidophosphonate (5a–d) derivatives containing the quinoline or quinolone moiety was designed and synthesized via Kabachnik–Fields reaction in the presence of ionic liquid under ultrasound irradiation. This efficient methodology provides new 1,2,5‐thiadiazolidine‐1,1‐dioxide derivatives 5a–d in one step and optimal conditions. The molecular structures of the novel compounds 4a–n and 5a–d were confirmed using various spectroscopic methods. All these compounds were evaluated for their in vitro antibacterial activity against Gram‐negative (Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) and Gram‐positive (Staphylococcus aureus ATCC 27923) bacteria, in addition to three clinical strains (E. coli 1, P. aeruginosa 1, and S. aureus 1). Most of the tested compounds showed more potent inhibitory activities against both Gram‐positive and ‐negative bacteria compared with the sulfamethoxazole reference. The following compounds, 4n, 4f, 4g, 4m, 4l, 4d, and 4e, are the most active sulfamidophosphonate derivatives. Furthermore, these molecules gave interesting zones of inhibition varying between 28 and 49 mm, against all tested bacterial strains, with a low minimum inhibitory concentration (MIC) value ranging from 0.125 to 8 μg/ml. All the synthesized derivatives were also evaluated for their in vitro antifungal activity against Fusarium oxyporum f. sp. lycopersici and Alternaria sp. The results revealed that all the synthesized compounds exhibited excellent antifungal inhibition and the compounds 4f, 4g, 4m, and 4i were the most potent derivatives with MIC values ranging from 0.25 to 1 µg/ml against the two tested fungal strains. The strongest inhibition of bacteria and fungi strains was detected by the effect of quinolone and sulfamide moieties. the microorganism is getting resistant with improvements in existing antibiotic classes by mutation membrane permeability and spore formation to the drugs by adapting themselves to withstand the potency of the drug. [5] Therefore, because of the limiting factor to the effectiveness of current drugs, the development of new treatment approaches and the synthesis of novel, effective, and more potent compounds to be used as chemotherapeutics is still in demand to overcome these problems. [6, 7] In this regard, sulfonamide and cyclosulfamide derivatives have been the focus of attention for chemists and biologists for a long time due to their wide range of biological and physical properties, [8] such as antibacterial, [9, 10] anticonvulsant, [11] antihypoglycemic, [12] anticancer, [13] herbicidal, [14] antifungal, [15] as well as their utility as synthetic intermediates. [16] In search of some new antibiotics, we have focused on sulfonamide and cyclic sulfamide moieties, which have significance in the area of medicinal chemistry [17] [18] [19] [20] [21] and drug development and are used as a core substituent of antibacterial agents, [22] for example, the sulfamethoxazole is an available sulfa drug acting as paraaminobenzoic acid competitive inhibitor. [23] [24] [25] Furthermore, a literature review revealed that the presence of quinoline derivatives exhibits good antibacterial activity [26] for the target compound and plays a significant role in the development of new antibacterial agents ( Figure 1 ). [27, 28] The great attention paid by researchers to the study of quinoline derivatives is explained by their broad range of biological activities, such as antiviral, [29] antioxidant, anti-inflammatory, [30] antimicrobial, [31] anti-atherothrombosis, [32] antiemetic, [33] anxiolytic, [34] antimalarial, and antileishmanial, [35] and recently, several reports have drawn attention to the use of chloroquine and hydroxychloroquine (antimalarial drugs), as inhibitors of SARS-CoV-2 virus. [36] [37] [38] In contrast, the α-aminophosphonate derivatives show great interest in organic synthesis because of their biological and pharmacological activities. [39] That is why the synthesis of new α-aminophosphonates is underway to find antibiotics, [40] enzyme inhibitors, [41] antileishmanial, [42] antifungal, [43] or antitumoral [44] compounds. The current work is an effort to develop novel formulations as effective antibacterial agents against drug-resistant bacterial strains. In this regard, the combination of certain sulfamides/sulfonamides and α-aminophosphonates moiety are very suitable for further modifications to obtain new α-sulfamidophosphonates or α-sulfonamidophosphonates as more cost-effective and more potent, pioneering antibacterial agents with minimum adverse effects [45] (Figure 2 ). Owing to such significance and keeping in view the wide range of pharmaceutical activities of sulfonamide, quinoline, and aminophosphonate scaffolds, in this report, we expect that the incorporation of all these moieties in the same scaffold structure may lead to good activities and potent antibacterial agents. Thus, a series of α-sulfamidophosphonate, sulfonamidophosphonate, and cyclosulfamidophosphonate derivatives bearing quinoline or quinolone rings was designed, synthesized, and evaluated for their antibacterial and antifungal activities. α-sulfamidophosphonate (4d-g, 4l-n), and cyclosulfamidophosphonate 5a-d (1,2,5-thiadiazolidine-1,1-dioxide) derivatives containing quinoline or quinolone moiety was designed and synthesized under ultrasound irradiation. In the first stage, we started our study with the synthesis of aldehyde derivatives and functionalized sulfonamides/sulfamides. The sulfonamides/sulfamides presented in this study as starting materials were obtained from a simple and efficient methodology described in the literature. [46] [47] [48] [49] 2-Chloro-quinoline-3-carbaldehyde derivatives 2a-e were obtained via Meth-Cohn reaction, [50] which included the condensation of acetanilide derivatives 1a-e with Vilsmeier-Haack reagent. As a continuation, 2-oxoquinoline 3-carbaldehyde derivatives (3a-e) were then obtained in good yields by the hydrolytic reaction of compounds 2a-e in the presence of 70% acetic acid. [51] In continuation of our program on the development and synthesis of novel compounds of α-aminophosphonate derivatives and to obtain these compounds in high yields and clean conditions, in this study, we have used our previous strategy for the synthesis of new α-sulfonamidophosphonate (4a-c, 4h-k), α-sulfamidophosphonate (4d-g, 4l-n), and cyclosulfamidophosphonate 5a-d derivatives in the presence of ionic liquid under ultrasound irradiation. It was F I G U R E 1 Structures of potent antimicrobial molecules containing quinoline and sulfonamide/sulfamide moieties previously reported by our research group [52] that in the absence of ionic liquid (triethylammonium acetate [TEAA]), the rates of the reaction were remarkably slowed and the yields were very low. The use of ionic liquid catalyst has gained importance in organic synthesis due to several advantages, such as short reaction time, excellent product yield, low cost, operational and simplicity of the reaction. Owing to the numerous advantages associated with this methodology, the application of ultrasonic irradiation to this reaction increases the efficiency, which otherwise requires a long reaction time. Moreover, ultrasound irradiations are believed to satisfy the demands of "green chemistry" by minimizing waste and reducing energy requirements, allowing for solvent-free conditions to be employed. Herein, we report a one-pot synthesis of α-sulfonamidophosphonate (4a-c, 4h-k), α-sulfamidophosphonate (4d-g, 4l-n) by condensation of quinoline/quinolone carbaldehyde (1 mmol), sulfonamide/ sulfamide (1 mmol), and triethylphosphite (1 mmol) catalyzed by ionic liquid (TEAA) and under solvent-free reaction using ultrasound irradiation. This method is an easy, rapid, one-pot, and good-yielding reaction. Thus, this methodology is also suitable for the synthesis of cyclosulfamidophosphonates 5a-d in one step (Scheme 1). The intramolecular cyclization "in situ" is realized in the same conditions and the desired products are obtained with a significant improvement in yield (up to 75%). So, this new methodology of multicomponent condensation reaction in one step is able to promote the synthesis of 1,2,5-thiadiazolidine-1,1-dioxide in short reaction time and ecofriendly conditions. The obtained results are summarized in Table 1 . Since the peak of N-H protons appeared as two broad singlets, ranged between 3 and 11 ppm only for compounds 4d-g and 4l-n, which have two NH functions of sulfamide group (NH-SO 2 -NH). Compounds 4a-c and 4h-k, on the contrary, have one NH function of sulfonamide group (NH-SO 2 -R). While, the intramolecular cyclization and the formation of the cycle thiadiazolidine 1,1-dioxide to afford the compounds 5a-e is also confirmed by the absence of a second NH peak and the presence of only broad singlet at 3-5 ppm. Additionally, these compounds revealed a similar singlet signal at 2.80-3.2 ppm that can be assigned to 2NCH 2 protons of the thiadiazolidine scaffold, according to the literature. [53] However, the last type of protons of aromatic rings is located between δ = 6.2 and 8 ppm. Elemental analysis furthermore confirms the assigned structures of the synthesized compounds. All these spectroscopic analyses confirm the obtaining of α-sulfamidophosphonates/sulfonamidophosphonates and cyclosulfamidophosphonates derivatives targeted in this study. Combinations of two or more active moieties into one scaffold are a common procedure for getting the synergistic effect to enhance the drug activity with less dose of the drug. infection. [56] In contrast, the diverse biological activities of α-aminophosphonates and sulfamides moieties mentioned above prompted us to test the antibacterial activities of the novel synthesized products. Hence, the 18 newly synthesized compounds were screened for their in vitro antimicrobial activity against selected strains of Gram-positive and -negative bacteria as well as two fungal strains. The sulfamidophosphonate/sulfonamidophosphonate and cyclosulfami- Initially, in vitro antibacterial activity of the α-sulfonamidophosphonate (4a-c, 4h-k), α-sulfamidophosphonate (4d-g, 4l-n), and cyclosulfamidophosphonate 5a-e derivatives was evaluated by agar well diffusion assay [57] using a concentration of 512 μg/ml. Subsequently, the zone of inhibition was measured in millimeters. The results are presented in Table 2 . To further determine the antibacterial effect of the tested compounds, the minimum inhibitory concentration (MIC) values and the minimum bactericidal concentration (MBC) against the abovementioned bacterial strains were measured by a broth dilution method. [58] [59] [60] The MIC value is defined as the lowest concentration of antibacterial agent that inhibits visible growth and the MBC value is the higher antibiotic concentration that will kill the organisms. The MIC and MBC values are summarized in Table 3 . It is obviously observed from the obtained results that all the newly synthesized compounds showed high antibacterial activity compared with the sulfamethoxazole reference (positive control). clearly seen that these derivatives contained a sulfamide function (NH-SO 2 -NH) and had respectively ortho-methoxyl, para-bromo, para-fluoro, and para-methyl substituents attached to the sulfamide ring, which exhibited strong electron-donating and/or electronwithdrawing properties, [25] which might have plausibly contributed to the potent antibacterial activity of these compounds. Antifungal activity of 18 newly synthesized compounds was de- Table 4 . According to the results (Table 3) While, the compounds 4e, 4l, 4n, 4g, and 4d also showed excellent inhibition and exhibited an MIC value between 0.5 and 2 µg/ml against both tested fungal strains in this study. In conclusion, the newly synthesized sulfamidophosphonate/ sulfonamidophosphonate 4a-n and cyclosulfamidophosphonate The in vitro antibacterial activity of all synthesized compounds was assayed against Gram-positive and -negative bacteria (S. aureus (ATCC 25923), E. coli (ATCC 25922), and P. aeruginosa (ATCC 27853)), in addition to three clinical strains (E. coli 1, S. aureus 1, and P. aeruginosa 1) according to agar disc diffusion method on solid medium Mueller-Hinton. [57] DMSO was used as a negative control and the antibacterial agent sulfamethoxazole as a positive control. The DIZ of each product was measured in millimeters in accordance with the recommendations of the Clinical and Laboratory Standards Institute. [63] Serial dilutions of the tested compounds were prepared in DMSO in a concentration range from 0.125 to 512 µg/ml. All tests were performed in triplicate. Antifungal activity of 18 newly synthesized compounds was determined in vitro against two phytopathogenic fungi strains (FOL and To identify the lowest inhibitory concentration, the test was repeated with serial dilutions of each product in a concentration range from 0.125 to 512 µg/ml. [64, 65] 1981(0), 1520; (b) O. Meth-Cohn, Heterocycle Flammarion Medicine Sciences. Flammarion médecine-sciences Performance Standards for Antimicrobial Susceptibility Testing How to cite this article: Bazine I, Bendjedid S, Boukhari A. Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety This study was supported by The General Directorate for Scientific Ministry of Scientific Research, Algeria. The authors declare that there are no conflicts of interests. http://orcid.org/0000-0001-6772-8379